These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 18692886

  • 1. A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
    Tripp K, McVicar WK, Nair P, Corren J, Pleskow WW, Goodwin E, Baumgartner RA, Hanrahan JP.
    J Allergy Clin Immunol; 2008 Sep; 122(3):544-9. PubMed ID: 18692886
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 3. Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.
    Hamilos DL, D'Urzo A, Levy RJ, Marcus M, Tripp K, Parsey M, Baumgartner RA, McVicar WK.
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):540-8. PubMed ID: 18219836
    [Abstract] [Full Text] [Related]

  • 4. Levalbuterol kinetics.
    Lipworth BJ, Clearie K.
    J Allergy Clin Immunol; 2009 Jan; 123(1):275. PubMed ID: 19130946
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
    Berger WE, Milgrom H, Skoner DP, Tripp K, Parsey MV, Baumgartner RA, Xopenex Pediatric Asthma Group.
    Curr Med Res Opin; 2006 Jun; 22(6):1217-26. PubMed ID: 16846555
    [Abstract] [Full Text] [Related]

  • 6. An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm.
    Pearlman DS, Rees W, Schaefer K, Huang H, Andrews WT.
    J Asthma; 2007 Nov; 44(9):729-33. PubMed ID: 17994402
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
    Langley SJ, Sykes AP, Batty EP, Masterson CM, Woodcock A.
    Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.
    Kerwin EM, Taveras H, Iverson H, Wayne D, Shah T, Lepore MS, Miller DS.
    Clin Drug Investig; 2016 Jan; 36(1):55-65. PubMed ID: 26541599
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
    Donohue JF, Wise R, Busse WW, Garfinkel S, Zubek VB, Ghafouri M, Manuel RC, Schlenker-Herceg R, Bleecker ER.
    BMC Pulm Med; 2016 Apr 30; 16(1):65. PubMed ID: 27130202
    [Abstract] [Full Text] [Related]

  • 10. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul 30; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 11. An evaluation of nebulized levalbuterol in stable COPD.
    Datta D, Vitale A, Lahiri B, ZuWallack R.
    Chest; 2003 Sep 30; 124(3):844-9. PubMed ID: 12970007
    [Abstract] [Full Text] [Related]

  • 12. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
    Ramsdell JW, Colice GL, Ekholm BP, Klinger NM.
    Ann Allergy Asthma Immunol; 1998 Dec 30; 81(6):593-9. PubMed ID: 9892032
    [Abstract] [Full Text] [Related]

  • 13. Proventil HFA and ventolin have similar safety profiles during regular use.
    Tinkelman DG, Bleecker ER, Ramsdell J, Ekholm BP, Klinger NM, Colice GL, Slade HB.
    Chest; 1998 Feb 30; 113(2):290-6. PubMed ID: 9498941
    [Abstract] [Full Text] [Related]

  • 14. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ, Allen D, McDonnell B, Wheeler N, Sharma RK, Sykes A, Woodcock A.
    Clin Ther; 2005 Jul 30; 27(7):1004-12. PubMed ID: 16154479
    [Abstract] [Full Text] [Related]

  • 15. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients.
    Gawchik SM, Saccar CL, Noonan M, Reasner DS, DeGraw SS.
    J Allergy Clin Immunol; 1999 Apr 30; 103(4):615-21. PubMed ID: 10200010
    [Abstract] [Full Text] [Related]

  • 16. Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter.
    Given J, Taveras H, Iverson H, Lepore M.
    Allergy Asthma Proc; 2013 Apr 30; 34(1):42-51. PubMed ID: 23265285
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the systemic pharmacodynamic effects and pharmacokinetics of salmeterol delivered by CFC propellant and non-CFC propellant metered dose inhalers in healthy subjects.
    Kempsford R, Handel M, Mehta R, De Silva M, Daley-Yates P.
    Respir Med; 2005 Apr 30; 99 Suppl A():S11-9. PubMed ID: 15777604
    [Abstract] [Full Text] [Related]

  • 18. Safety of long-term treatment with HFA albuterol.
    Ramsdell JW, Klinger NM, Ekholm BP, Colice GL.
    Chest; 1999 Apr 30; 115(4):945-51. PubMed ID: 10208190
    [Abstract] [Full Text] [Related]

  • 19. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction.
    Hawksworth RJ, Sykes AP, Faris M, Mant T, Lee TH.
    Ann Allergy Asthma Immunol; 2002 May 30; 88(5):473-7. PubMed ID: 12027068
    [Abstract] [Full Text] [Related]

  • 20. A Dose-Ranging Study of Epinephrine Hydrofluroalkane Metered-Dose Inhaler (Primatene® MIST) in Subjects with Intermittent or Mild-to-Moderate Persistent Asthma.
    Kerwin EM, Tashkin DP, Murphy TR, Bensch GW, Marrs T, Luo MZ, Zhang JY.
    J Aerosol Med Pulm Drug Deliv; 2020 Aug 30; 33(4):186-193. PubMed ID: 32150492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.